NVO, INSP, TSLA, TGNA and more

NVO, INSP, TSLA, TGNA and more

Check out the companies making the biggest moves midday: Novo Nordisk — The Danish pharmaceutical company’s trial for Alzheimer’s disease failed to meet its main goal of slowing the disease’s progression. Shares tumbled nearly 6%. Inspire Medical Systems — The maker of an obstructive sleep apnea treatment will benefit from Friday’s decision by the Centers…

Read More
We’re buying more shares of this cybersecurity giant after a tough post-earnings stretch

We’re buying more shares of this cybersecurity giant after a tough post-earnings stretch

We are buying 40 shares of Palo Alto Networks at roughly $185 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 450 shares of PANW, increasing its weighting to 2.25% from about 2.05%. We’re picking up more shares of this cybersecurity leader that has fallen significantly since earnings. The stock has tumbled about $15,…

Read More
Selling an options ‘strangle’ on this retail giant on Mike Khouw’s holiday shopping list

Selling an options ‘strangle’ on this retail giant on Mike Khouw’s holiday shopping list

Continuing the theme of our holiday shopping list of stocks is particularly appropriate, given that this is one of the most significant shopping weeks of the year. “Black Friday” is the informal name for the Friday immediately following the U.S. Thanksgiving holiday, which marks the traditional start of the holiday shopping season and is known…

Read More
Novo Nordisk shares plunge after Alzheimer’s drug trial fails to hit key target

Novo Nordisk shares plunge after Alzheimer’s drug trial fails to hit key target

The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg | Getty Images Shares of Novo Nordisk on Monday fell as much 11% after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer’s disease failed to meet its main goal. The trial tested whether semaglutide — the…

Read More